Modified Nucleosides
2',3'-Dideoxy-2',3'-didehydro-cytidine
Quick view. We supply 2',3'-Dideoxy-2',3'-didehydro-cytidine as a specialty product for nucleic acid chemistry and oligonucleotide research workflows. CAS 7481-88-1. Catalog target purity: Specification on request.
Product profile
2',3'-Dideoxy-2',3'-didehydro-cytidine is classified as nucleoside or protected nucleoside intermediate (Formula C9H11N3O3; molecular weight 209.2).
2',3'-Dideoxy-2',3'-didehydro-cytidine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 2',3'-Dideoxy-2',3'-didehydro-cytidine, reported solubility: DMSO (Slightly), Ethanol (Slightly, Sonicated). Storage: Hygroscopic, -20°C Freezer, Under inert atmosphere.
Names and search terms
Confirmed or normalized name variants
- 2',3'-didehydro-2',3'-dideoxycytidine
- D4C
- Dideoxycytidinene
- 2',3'-dideoxycytidinene
- Zalcitabine Related CoMpound A
- 2,3’-didehydro-2’,3’-dideoxy-cytidin
- Cytidine, 2',3'-didehydro-2',3'-dideoxy-
- 2’,3’-Dideoxy-2’,3’-didehydro-cytidine, D4C
Useful catalog search terms
- CAS 7481-88-1
- Nucleoside or protected nucleoside intermediate
- Modified Nucleosides
Physicochemical data
| InChI | InChI=1S/C9H11N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h1-4,6,8,13H,5H2,(H2,10,11,14)/t6-,8+/m0/s |
|---|---|
| InChIKey | OOBICGOWICFMIX-POYBYMJQSA-N |
| SMILES | C1=C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N |
| Melting point | 168-169℃ (ethanol ) |
| Boiling point | 425.4±55.0 °C(Predicted) |
| Density | 1.56±0.1 g/cm3(Predicted) |
| pKa | 14.28±0.10(Predicted) |
| Form | Solid |
| Color | Off-White to Pale Yellow |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Product-specific evaluation notes
Potential advantages
- Dideoxy analogs provide clear extension-stop behavior when accepted by a polymerase.
Method limitations
- Polymerase acceptance varies; absence of a 3′-OH prevents further extension after incorporation.
These points describe 2',3'-Dideoxy-2',3'-didehydro-cytidine or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosylmethionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-0185(R-/S-) 5-Carbamoylhydroxy methyluridine
Modified Nucleosides · CAS: N/A
BX-MN-0186(R-/S-)5-(1-Hydroxy)(methoxycarbonyl)methyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0187(R-/S-)5-Carboxyhydroxymethyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0719(R)-N-(2,3-dihydro-1H-indenyl)adenosine
Modified Nucleosides · CAS: 96392-15-3
Frequently asked questions
Can the package size for 2',3'-Dideoxy-2',3'-didehydro-cytidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0666 and CAS 7481-88-1, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry.